Subscribe

Life Healthcare Group Holdings Limited (LHC.JO)

ZAc1,075.00 -2.00 (-0.19%)
ZA JNB Healthcare Medical - Care Facilities
Address Oxford Parks 2196
Johannesburg, ZA
CEO Peter Gerard Wharton-Hood Harvard
Website lifehealthcare.co.za
IPO 2000-01-04
ISIN ZAE000145892

Explore sections of this company profile

Also trades on Johannesburg Stock Exchange · LHC.JO (ZAc) Other OTC · LTGHF (USD) Other OTC · LTGHY (USD)
Description

Headquartered in Johannesburg, South Africa, Life Healthcare Group Holdings Limited, established in 1983, operates as a prominent international provider of private hospital services. Its extensive operations span South Africa, Canada, the United Kingdom, various other European countries, and broader international markets. The company's business is structured into two principal divisions: Hospitals and Complementary Services, and Healthcare Services. It delivers a comprehensive range of acute hospital care alongside diverse complementary offerings. These include the specialized services of Life Esidimeni, which covers chronic mental healthcare, frail care, rehabilitation, step-down facilities, correctional healthcare, primary care, and substance abuse recovery programs. Additionally, its Life Employee Health Solutions segment provides on-site occupational health, primary healthcare, and employee wellness initiatives. The company's medical expertise extends across numerous fields, such as diagnostics, mental health treatment, acute rehabilitation, renal dialysis, oncology, cardiology, neurology, orthopedics, pediatrics, dermatology, ophthalmology, gynecology, and obstetrics. Furthermore, Life Healthcare is involved in advanced diagnostic imaging, operating magnetic resonance imaging (MRI) and computerized tomography (CT) scanners, and both developing and distributing radiopharmaceuticals vital for positron emission tomography-computerized tomography (PET-CT) diagnostics. The organization was formerly known as Afrox Healthcare Limited until its name change to Life Healthcare Group Holdings Limited in January 2005.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
ZAc1,075.00 -2.00 (-0.19%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
3M
Beta
0.07
Float Shares
1.33B
Free Float %
93.1%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-0.37% -4.63% -13.57% -11.72% -1.02% -6.06% -25.23% -42.57% -50.69% -70.11% -76.22%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
1,075.00
DCF (Unlevered) 1,991.49 +85.3%
DCF (Levered) 8,521.88 +692.7%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 20% Bullish
Rating 2026-05 Change
Strong Buy 1 0
Buy 0 0
Hold 4 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
3.87
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
2 / 10
No MOAT
Composite Rating
A+
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Medical - Care Facilities: +10.2%
    -2.7% Q1'26: +109.5% (vs Q1'24)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +92.8% ★ Q1'26: -78.0% (vs Q1'24)
  • ✗
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    -3.7% Q1'26: +2.5% (vs Q1'24)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    -1.1% Q1'26: +9.2% (vs Q1'24)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    -2.2% Q1'26: +20.9% (vs Q1'24)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    0.0% ★ Q1'26: -0.5% (vs Q1'24)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    3.81× ★ Q1'26: 0.66× (vs Q1'24)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.16) × ERP
WACC = 80% × Ke + 20% × Kd (8.7%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 1,991.49 Current price: 1,075.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Sep 2015
actual 		Sep 2016
actual 		Sep 2017
actual 		Sep 2018
actual 		Sep 2019
actual 		Sep 2020
actual 		Sep 2021
actual 		Sep 2022
actual 		Sep 2023
actual 		Sep 2024
actual 		Sep 2025
actual 		Sep 2026
4 Rev. Ana.
3 EPS Ana. 		Sep 2027
4 Rev. Ana.
3 EPS Ana. 		Sep 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
14.65B
est: 14.74B (-0.7%)
16.40B
est: 16.31B (+0.6%)
20.80B
est: 20.62B (+0.8%)
23.49B
est: 23.36B (+0.6%)
25.67B
est: 25.55B (+0.5%)
25.39B
est: 25.24B (+0.6%)
26.89B
est: 26.70B (+0.7%)
20.53B
est: 28.39B (-27.7%)
22.64B
est: 23.76B (-4.7%)
25.79B
est: 25.12B (+2.7%)
25.10B
est: 25.65B (-2.1%)
26.31B
26.23B – 26.39B
+2.6% YoY
27.58B
27.11B – 28.77B
+4.8% YoY
28.82B
28.52B – 29.50B
+4.5% YoY
EBITDA
4.12B
est: 2.13B (+93.6%)
4.05B
est: 2.35B (+72.0%)
4.66B
est: 2.97B (+56.7%)
5.58B
est: 3.37B (+65.9%)
6.28B
est: 3.68B (+70.4%)
4.16B
est: 3.64B (+14.4%)
5.06B
est: 3.85B (+31.5%)
3.52B
est: 4.09B (-14.0%)
3.62B
est: 3.42B (+5.5%)
4.13B
est: 3.62B (+14.0%)
1.04B
est: 3.70B (-72.0%)
3.79B
3.78B – 3.80B
+2.6% YoY
3.98B
3.91B – 4.15B
+4.8% YoY
4.15B
4.11B – 4.25B
+4.5% YoY
EBIT
3.39B
est: 1.34B (+153.1%)
3.18B
est: 1.48B (+114.1%)
3.04B
est: 1.88B (+62.2%)
3.57B
est: 2.12B (+67.9%)
4.45B
est: 2.32B (+91.6%)
2.11B
est: 2.30B (-8.0%)
2.96B
est: 2.43B (+21.8%)
2.55B
est: 2.58B (-1.3%)
2.49B
est: 2.16B (+15.2%)
3.15B
est: 2.28B (+37.8%)
-275.00M
est: 2.33B (-111.8%)
2.39B
2.39B – 2.40B
+2.6% YoY
2.51B
2.47B – 2.62B
+4.8% YoY
2.62B
2.59B – 2.68B
+4.5% YoY
Net Income
1.87B
est: 2.38B (-21.5%)
1.62B
est: 2.14B (-24.5%)
814.00M
est: 1.36B (-40.0%)
1.58B
est: 1.43B (+10.3%)
2.57B
est: 1.49B (+72.5%)
38.00M
est: 751.17M (-94.9%)
1.75B
est: 1.25B (+40.8%)
1.53B
est: 1.42B (+8.0%)
264.00M
est: 1.41B (-81.3%)
4.83B
est: 1.48B (+225.5%)
3.86B
est: 2.07B (+86.8%)
1.77B
1.69B – 1.85B
-14.5% YoY
2.00B
1.79B – 2.20B
+13.0% YoY
2.17B
2.14B – 2.24B
+8.7% YoY
SGA
154.00M
est: 701.40M (-78.0%)
181.00M
est: 775.95M (-76.7%)
292.00M
est: 981.13M (-70.2%)
691.00M
est: 1.11B (-37.8%)
947.00M
est: 1.22B (-22.1%)
875.00M
est: 1.20B (-27.1%)
917.00M
est: 1.27B (-27.8%)
1.00B
est: 1.35B (-25.7%)
1.15B
est: 1.13B (+1.7%)
1.44B
est: 1.19B (+20.3%)
1.21B
est: 1.22B (-0.6%)
1.25B
1.25B – 1.26B
+2.6% YoY
1.31B
1.29B – 1.37B
+4.8% YoY
1.37B
1.36B – 1.40B
+4.5% YoY
EPS
1.57
est: 1.64 (-4.1%)
1.44
est: 1.47 (-2.3%)
0.62
est: 0.93 (-33.6%)
1.09
est: 0.98 (+10.9%)
1.76
est: 1.02 (+71.7%)
0.03
est: 0.52 (-95.0%)
1.15
est: 0.86 (+34.1%)
1.06
est: 0.98 (+8.6%)
0.18
est: 0.98 (-81.6%)
1.38
est: 1.01 (+36.4%)
2.69
est: 1.42 (+88.9%)
1.21
1.16 – 1.27
-14.7% YoY
1.34
1.24 – 1.52
+10.5% YoY
1.50
1.47 – 1.54
+11.5% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-28 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-27 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-26 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-25 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-22 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-21 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-20 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-19 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-18 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-15 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-14 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-13 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-12 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-11 A+ 4/5 5/5 5/5 5/5 2/5 3/5 4/5
2026-05-08 A+ 5/5 5/5 5/5 5/5 2/5 4/5 4/5
2026-05-07 A+ 5/5 5/5 5/5 5/5 2/5 4/5 4/5
2026-05-06 A+ 5/5 5/5 5/5 5/5 2/5 4/5 4/5
2026-05-05 A+ 5/5 5/5 5/5 5/5 2/5 4/5 4/5
2026-05-04 A+ 5/5 5/5 5/5 5/5 2/5 4/5 4/5
2026-04-30 A+ 5/5 5/5 5/5 5/5 2/5 4/5 4/5
2026-04-29 A+ 4/5 5/5 5/5 5/5 1/5 4/5 4/5
2026-04-28 A+ 4/5 5/5 5/5 5/5 1/5 4/5 4/5
2026-04-24 A+ 4/5 5/5 5/5 5/5 1/5 4/5 4/5
2026-04-23 A 4/5 5/5 5/5 5/5 1/5 3/5 4/5
2026-04-22 A 4/5 5/5 5/5 5/5 1/5 3/5 4/5
2026-04-21 A 4/5 5/5 5/5 5/5 1/5 3/5 4/5
2026-04-20 A 4/5 5/5 5/5 5/5 1/5 3/5 4/5
2026-04-17 A 4/5 5/5 5/5 5/5 1/5 3/5 4/5
2026-04-16 A 4/5 5/5 5/5 5/5 1/5 3/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
9.58B
OE per share TTM
6.61
Owner's Yield
62.68%
Maintenance CapEx ratio
358.56%
Maint CapEx / Avg PPE
53.0%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 67 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 WisdomTree Emerging Markets Equity Income UCITS ETF DEMD.L 0.12% 319.1K 0.46%
2 WisdomTree Emerging Markets Equity Income UCITS ETF - Acc DEMR.L 0.12% 319.1K 0.46%
3 WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L 0.11% 48.2K 0.54%
4 FlexShares Morningstar Emerging Markets Factor Tilt Index Fund TLTE 0.10% 332.4K 0.58%
5 Avantis Emerging Markets Small Cap Equity ETF AVEE 0.09% 112.3K 0.42%
6 WisdomTree Emerging Markets High Dividend Fund DEM 0.09% 3.60M 0.63%
7 iShares Ageing Population UCITS ETF AGED.L 0.07% 577.4K 0.40%
8 State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L 0.06% 390.9K 0.55%
9 WisdomTree Emerging Markets SmallCap Dividend Fund DGS 0.06% 990.0K 0.58%
10 iShares MSCI EM Small Cap UCITS ETF IEMS.L 0.05% 188.2K 0.74%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
-16.2K
Shares Outstanding
1.43B

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Peter Gerard Wharton-Hood Harvard Chief Executive Officer & Executive Director 29M male
Pieter Phillippus van der Westhuizen Chief Financial Officer & Executive Director 20M male
Adam Pyle Chief Strategy & Growth Officer and Executive Head of Investor Relations 9M male
Craig Koekemoer Chief Operations Officer — male
David Price Chief Information Officer — male
Joshila Ranchhod Group Company Secretary — female
Karisha Quarrie Chief Medical Officer — —
Merle Victor Chief Nurse Officer — female
Brett Mill Chief Actuary & Risk Officer — male
Avanthi Parboosing Chief People Officer — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities